While metabolic pathways remain blocked, hyperinsulinemia selectively activates renal growth pathways, promoting cellular hypertrophy and fibrosis via redox-sensitive kinases (ERK, JNK, mTOR/S6K1) (21). The gene discussed is MTOR; the disease is Hyperinsulinemia.